8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,694) Views
Editor in Chief Professor Garry Walsh
1178-203X
Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese
Xiao Hui Liang, Wai Cheung, Chew Kiat Heng, De-Yun Wang
Therapeutics and Clinical Risk Management 2005, 1:243-246
20 January 2005
Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3
Shenxian Qian, George Somlo, Bingsen Zhou, Yun Yen
Therapeutics and Clinical Risk Management 2005, 1:231-241
20 January 2005
Gastrointestinal bleeding and massive liver damage in neuroleptic malignant syndrome
Guido Mannaioni, Roberto Baronti, Flavio Moroni
Therapeutics and Clinical Risk Management 2005, 1:225-229
20 January 2005
Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia
Madeleine Nowak, Petra Büttner, Beverly Raasch, Kym Daniell, Cindy McCutchan, Simone Harrison
Therapeutics and Clinical Risk Management 2005, 1:219-224
20 January 2005
Influence of anatomical site and topical formulation on skin penetration of sunscreens
Heather AE Benson, Vikram Sarveiya, Stacey Risk, Michael S Roberts
Therapeutics and Clinical Risk Management 2005, 1:209-218
20 January 2005
Inhibitors of selectin functions in the treatment of inflammatory skin disorders
Michael P Schön
Therapeutics and Clinical Risk Management 2005, 1:201-208
20 January 2005
The challenge of patient adherence
Leslie R Martin, Summer L Williams, Kelly B Haskard, M Robin DiMatteo
Therapeutics and Clinical Risk Management 2005, 1:189-199
20 January 2005
Adverse drug reaction reporting in New Zealand: implications for pharmacists
Monica Zolezzi, Nirasha Parsotam
Therapeutics and Clinical Risk Management 2005, 1:181-188
20 January 2005
Sputum analysis in diagnosis and management of obstructive airway diseases
Paige Lacy, Jennifer L Lee, Dilini Vethanayagam
Therapeutics and Clinical Risk Management 2005, 1:169-179
20 January 2005
Editorial || FREE PAPER ||
Garry Walsh
Therapeutics and Clinical Risk Management 2005, 1:167-167
12 May 2005
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
